Altus Pharmaceuticals Inc. Receives NASDAQ Notice of Noncompliance
Published: Aug 11, 2009
WALTHAM, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (Nasdaq: ALTU) today announced that on August 7, 2009 it was advised by The NASDAQ Stock Market (NASDAQ) that, based on the Company’s stockholders equity as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2009, the Company is no longer in compliance with the $10 million minimum stockholders’ equity requirement for continued listing on The NASDAQ Global Market under NASDAQ Listing Rule 5450(b)(1)(A). As of June 30, 2009, the Company’s stockholders’ equity was approximately $5.8 million. This notification has no immediate effect on the Company’s listing on The NASDAQ Global Market or on the trading of the Company’s common stock.